ClinicalTrials.govpublic full text
A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
obesity, glp-1r agonist, semaglutide, nausea, vomiting, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 895513
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.